MPQ-PRI (0 – 45) | Pre-treatment (T0) | Mid-treatment (T1) | Post-treatment (T2) |  |
---|---|---|---|---|
Mean (SD) | 18.5 (9.0) | 17.1 (10.0) | 15.1 (10.8) | Â |
  pre- to mid- | ||||
    p value |  | 0.07 |  |  |
    Cohen's d (95% CI) |  | 0.18 (-0.01–0.38) |  |  |
  mid- to post- | ||||
    p value |  |  | 0.02 |  |
    Cohen's d (95% CI) |  |  | 0.24 (0.05–0.44) |  |
 pre- to post- | ||||
    p value |  |  |  |  < 0.001 |
    Cohen's d (95% CI) |  |  |  | 0.33 (0.13–0.52) |
FM (0 – 10) | Pre-treatment (T0) | Mid-treatment (T1) | Post-treatment (T2) |  |
Mean (SD) | 7.6 (2.1) | 6.6 (2.4) | 5.9 (2.9) | Â |
  pre- to mid- | ||||
    p value |  |  < 0.001 |  |  |
    Cohen's d (95% CI) |  | 0.49 (0.28–0.69) |  |  |
  mid- to post- | ||||
    p value |  |  | 0.01 |  |
    Cohen's d (95% CI) |  |  | 0.26 (0.06–0.45) |  |
  pre- to post- | ||||
    p value |  |  |  |  < 0.001 |
    Cohen's d (95% CI) |  |  |  | 0.66 (0.45–0.87) |